![]()
|
|
||||||||
JBC, Vol. 251, Issue 16, 4833-4838, Aug, 1976
M. S. Chen, D. C. Ward and W. H. Prusoff
5-Iodo-5'-amino-2',5'-dideoxyuridine (AIdUrd) is a novel thymidine analog
which inhibits herpes simplex virus, type 1 (HS-1 virus) replication in the
absence of detectable host toxicity. When murine, simian, or human cells in
culture are treated with [125I]AIdUrd for up to 24 hours essentially none
of the nucleoside becomes cell-associated. In contrast, upon HS-1 virus
infection significant radiolabel is detected in both nucleotide pools and
in DNA. The major acid-soluble metabolite has been shown by enzymic and
chromatographic analysis to be the 5'-triphosphate of AIdUrd. DNA from HS-1
virus-infected Vero cells labeled with [14C]thymidine,
5-[125I]iodo-2'-deoxyuridine (IdUrd), or [125I]AIdUrd was isolated by
buoyant density centrifugation and subjected to digestion by pancreatic
DNase I, spleen DNase II, micrococcal nuclease, spleen, and venom
phosphodiesterases. Analysis of the digestion products clearly indicate
that AIdUrd is incorporated internally into the DNA structure. DNA
containing AIdUrd therefore contains phosphoramidate (P-N) bonds, known to
be extremely acid-labile. The selective HS-1 virus-induced phosphorylation
of AIdUrd and its subsequent incorporation into DNA may account for the
unique biological activity of the AIdUrd nucleoside.
Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Cohen A strategy for the chemotherapy of infectious disease Science, July 29, 1977; 197(4302): 431 - 432. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |